PubRank

Hirohito Kita

Author PubWeight™ 124.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol 2008 2.97
2 A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 2008 2.78
3 Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol 2012 2.68
4 IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol 2011 2.54
5 School examinations enhance airway inflammation to antigen challenge. Am J Respir Crit Care Med 2002 2.41
6 The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 2011 2.33
7 Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2012 2.09
8 Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol 2009 1.96
9 IL-33-activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol 2009 1.92
10 Asthma outcomes: biomarkers. J Allergy Clin Immunol 2012 1.88
11 The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 2004 1.84
12 Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005 1.84
13 Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002 1.63
14 Eosinophilic-lymphocytic myocarditis after smallpox vaccination. Lancet 2003 1.58
15 Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope 2009 1.54
16 Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004 1.52
17 The involvement of glucocorticoids in psychological stress-induced exacerbations of experimental allergic asthma. Int Arch Allergy Immunol 2014 1.43
18 Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia. Clin Gastroenterol Hepatol 2012 1.40
19 Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways. J Immunol 2008 1.29
20 Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis. J Allergy Clin Immunol 2005 1.27
21 Asthma-related environmental fungus, Alternaria, activates dendritic cells and produces potent Th2 adjuvant activity. J Immunol 2009 1.26
22 Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow. J Immunol 2011 1.22
23 Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. Am J Gastroenterol 2009 1.21
24 Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J Immunol 2003 1.17
25 Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma. J Allergy Clin Immunol 2010 1.16
26 CD38-deficient mice have reduced airway hyperresponsiveness following IL-13 challenge. Am J Physiol Lung Cell Mol Physiol 2006 1.15
27 Retracted Dendritic cells activated by cross-linking B7-DC (PD-L2) block inflammatory airway disease. J Allergy Clin Immunol 2005 1.15
28 Dynamic role of epithelium-derived cytokines in asthma. Clin Immunol 2012 1.14
29 Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol 2005 1.12
30 Intranasal exposure to staphylococcal enterotoxin B elicits an acute systemic inflammatory response. Shock 2006 1.10
31 Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol 2003 1.09
32 Retracted Blockade of allergic airway inflammation following systemic treatment with a B7-dendritic cell (PD-L2) cross-linking human antibody. J Immunol 2004 1.09
33 Childhood asthma and measles vaccine response. Ann Allergy Asthma Immunol 2006 1.09
34 Nicotine and oxidative cigarette smoke constituents induce immune-modulatory and pro-inflammatory dendritic cell responses. Mol Immunol 2008 1.08
35 Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci 2006 1.07
36 Role of CD38 in TNF-alpha-induced airway hyperresponsiveness. Am J Physiol Lung Cell Mol Physiol 2007 1.06
37 Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect Immun 2006 1.05
38 Influence of asthma status on serotype-specific pneumococcal antibody levels. Postgrad Med 2010 1.05
39 Human eosinophils are activated by cysteine proteases and release inflammatory mediators. J Allergy Clin Immunol 2003 1.04
40 Regulation of TLR2 expression and function in human airway epithelial cells. J Membr Biol 2009 1.02
41 CD66b regulates adhesion and activation of human eosinophils. J Immunol 2007 1.02
42 Human eosinophils recognize endogenous danger signal crystalline uric acid and produce proinflammatory cytokines mediated by autocrine ATP. J Immunol 2010 1.02
43 Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancer. J Thorac Oncol 2007 1.01
44 Innate antifungal immunity of human eosinophils mediated by a beta 2 integrin, CD11b. J Immunol 2008 0.98
45 Recognition of fungal protease activities induces cellular activation and eosinophil-derived neurotoxin release in human eosinophils. J Immunol 2009 0.97
46 Platelet-activating factor stimulates cytoplasmic alkalinization and granule acidification in human eosinophils. J Cell Sci 2004 0.96
47 Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 2002 0.96
48 Increases in airway eosinophilia and a th1 cytokine during the chronic asymptomatic phase of asthma. Respir Med 2010 0.94
49 Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis. PLoS One 2010 0.94
50 Three-dimensional volumetric computed tomographic scoring as an objective outcome measure for chronic rhinosinusitis: clinical correlations and comparison to Lund-Mackay scoring. Int Forum Allergy Rhinol 2013 0.93
51 Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr Opin Allergy Clin Immunol 2015 0.93
52 Preoperative evaluation of patients with history of allergy to penicillin: comparison of 2 models of practice. Mayo Clin Proc 2008 0.91
53 Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg 2002 0.91
54 Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions. J Allergy Clin Immunol 2005 0.91
55 Human airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the Ras-ERK pathway when compared with blood eosinophils. J Immunol 2010 0.91
56 Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum. Chest 2008 0.90
57 Regulation of eosinophil membrane depolarization during NADPH oxidase activation. J Cell Sci 2003 0.90
58 Transcription of interleukin-25 and extracellular release of the protein is regulated by allergen proteases in airway epithelial cells. Am J Respir Cell Mol Biol 2013 0.90
59 Innate immunomodulatory effects of cereal grains through induction of IL-10. J Allergy Clin Immunol 2007 0.89
60 Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase. J Biol Chem 2008 0.88
61 Alternaria fungus induces the production of GM-CSF, interleukin-6 and interleukin-8 and calcium signaling in human airway epithelium through protease-activated receptor 2. Int Arch Allergy Immunol 2012 0.88
62 Oxidized low-density lipoprotein activates migration and degranulation of human granulocytes. Am J Respir Cell Mol Biol 2003 0.88
63 The role of ubiquitous airborne fungi in chronic rhinosinusitis. Clin Rev Allergy Immunol 2006 0.88
64 Airway uric acid is a sensor of inhaled protease allergens and initiates type 2 immune responses in respiratory mucosa. J Immunol 2014 0.88
65 Acute exacerbations of chronic rhinosinusitis occur in a distinct seasonal pattern. J Allergy Clin Immunol 2010 0.87
66 Degranulation of human eosinophils induced by Paragonimus westermani-secreted protease. Korean J Parasitol 2005 0.87
67 Biological activities of ecalectin: a novel eosinophil-activating factor. J Immunol 2002 0.87
68 Dual signaling and effector pathways mediate human eosinophil activation by platelet-activating factor. Int Arch Allergy Immunol 2004 0.87
69 Platelet-activating factor activates two distinct effector pathways in human eosinophils. J Immunol 2002 0.86
70 Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol 2004 0.85
71 An 8-year-old boy with hypereosinophilic syndrome. Int Arch Allergy Immunol 2011 0.85
72 Cockroach induces inflammatory responses through protease-dependent pathways. Int Arch Allergy Immunol 2011 0.85
73 Antigen-specific IgG and IgA, but not IgE, activate the effector functions of eosinophils in the presence of antigen. Int Arch Allergy Immunol 2010 0.84
74 ATP release and Ca2+ signalling by human bronchial epithelial cells following Alternaria aeroallergen exposure. J Physiol 2013 0.84
75 Extensive fractionation and identification of proteins within nasal lavage fluids from allergic rhinitis and asthmatic chronic rhinosinusitis patients. J Sep Sci 2009 0.84
76 Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions. J Allergy Clin Immunol 2005 0.84
77 T-bet expression by dendritic cells is required for the repolarization of allergic airway inflammation. Eur J Immunol 2008 0.84
78 The synthetic chemoattractant peptide WKYMVm induces superoxide production by human eosinophils via the phosphoinositide 3-kinase-mediated activation of ERK1/2. Int Arch Allergy Immunol 2005 0.84
79 Excretory-secretory products secreted by Paragonimus westermani delay the spontaneous cell death of human eosinophils through autocrine production of GM-CSF. Int Arch Allergy Immunol 2003 0.84
80 Severity of childhood asthma and human leukocyte antigens type. J Asthma 2007 0.83
81 Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549). Cell Biol Int 2011 0.83
82 The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation. Pediatr Allergy Immunol 2010 0.83
83 Pathogenesis of chronic rhinosinusitis: role of airborne fungi and bacteria. Immunol Allergy Clin North Am 2004 0.83
84 Ovalbumin content of influenza vaccines. J Allergy Clin Immunol 2010 0.83
85 Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough. J Asthma 2011 0.83
86 Comparison of the effects of repetitive low-dose and single-dose antigen challenge on airway inflammation. J Allergy Clin Immunol 2003 0.83
87 Systemic reactions to allergen immunotherapy: a role for measuring a PGD2 metabolite? Ann Allergy Asthma Immunol 2012 0.82
88 Induction of malignant plasma cell proliferation by eosinophils. PLoS One 2013 0.82
89 Eosinophil granular proteins damage bronchial epithelial cells infected with respiratory syncytial virus. Int Arch Allergy Immunol 2012 0.82
90 Alternaria inhibits double-stranded RNA-induced cytokine production through Toll-like receptor 3. Int Arch Allergy Immunol 2013 0.82
91 Human eosinophil innate response to Alternaria fungus through protease-activated receptor-2. Int Arch Allergy Immunol 2011 0.82
92 Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice. J Mol Cell Cardiol 2007 0.82
93 The role of ubiquitous airborne fungi in chronic rhinosinusitis. Curr Allergy Asthma Rep 2005 0.81
94 Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. J Allergy Clin Immunol 2004 0.81
95 IL-1 family cytokines drive Th2 and Th17 cells to innocuous airborne antigens. Am J Respir Cell Mol Biol 2013 0.81
96 A proposed model to study immunologic changes during chronic rhinosinusitis exacerbations: data from a pilot study. Am J Rhinol Allergy 2013 0.81
97 Blood and sputum eosinophil levels in asthma and their relationship to sinus computed tomographic findings. Mayo Clin Proc 2008 0.80
98 A 27 kDa cysteine protease secreted by newly excysted Paragonimus westermani metacercariae induces superoxide anion production and degranulation of human eosinophils. Korean J Parasitol 2008 0.80
99 Serum 25-hydroxyvitamin D concentrations and waning pneumococcal antibody titers among individuals with atopy. Allergy Asthma Proc 2013 0.79
100 The role of ubiquitous airborne fungi in chronic rhinosinusitis. Clin Allergy Immunol 2007 0.79
101 Covalent interaction between proform of eosinophil major basic protein (proMBP) and pregnancy-associated plasma protein-A (PAPP-A) is a cell-mediated event and required for proMBP inhibition of the catalytic activity of PAPP-A. Arch Biochem Biophys 2004 0.79
102 Studies on regulation of IGF (insulin-like growth factor)-binding protein (IGFBP) 4 proteolysis by pregnancy-associated plasma protein-A (PAPP-A) in cells treated with phorbol ester. Biochem J 2004 0.79
103 Inflammatory responses of human eosinophils to cockroach are mediated through protease-dependent pathways. J Allergy Clin Immunol 2010 0.79
104 Computed tomography scans as an objective measure of disease severity in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2013 0.79
105 The chemotactic behavior of eosinophils in patients with chronic rhinosinusitis. Laryngoscope 2003 0.78
106 The effect of nasal polyp epithelial cells on eosinophil activation. Laryngoscope 2003 0.78
107 Neuropeptide levels in nasal secretions from patients with and without chronic cough. Ann Allergy Asthma Immunol 2011 0.78
108 Beta2-integrin-mediated adhesion and intracellular Ca2+ release in human eosinophils. J Membr Biol 2009 0.78
109 TLR3 activation evokes IL-6 secretion, autocrine regulation of Stat3 signaling and TLR2 expression in human bronchial epithelial cells. J Cell Commun Signal 2012 0.78
110 Serum 25-hydroxyvitamin D is associated with enhanced pneumococcal antibody levels in individuals with asthma. Allergy Asthma Proc 2012 0.77
111 Inhibition of MEK pathway in vestibular schwannoma cell culture. Laryngoscope 2012 0.77
112 Antifungal therapy for chronic rhinosinusitis: the controversy persists. Curr Opin Allergy Clin Immunol 2009 0.77
113 Elevated numbers of cells producing interleukin-5 and interleukin-10 in a boy with Kimura disease. Int Arch Allergy Immunol 2012 0.76
114 Is ROG, repressor of GATA, a specific regulator of Th2-type immune response? Clin Immunol 2011 0.76
115 Gene transcription abnormalities in canine atopic dermatitis and related human eosinophilic allergic diseases. Vet Immunol Immunopathol 2012 0.76
116 Pimecrolimus reduces eosinophil activation associated with calcium mobilization. Int Arch Allergy Immunol 2009 0.75
117 Reduced immunoglobulin M is associated with sinus mucosal thickening, osteitis and sinus surgery in patients with common variable immunodeficiency. Int Arch Allergy Immunol 2009 0.75
118 The Role of IL-17 in the Association between Pneumococcal Pneumonia and Allergic Sensitization. Int J Microbiol 2011 0.75
119 Analysis of fluticasone propionate in induced sputum by mass spectrometry. Allergy Asthma Proc 2011 0.75
120 An immunologic test for chronic rhinosinusitis based on free intranasal eosinophilic major basic protein. Int Forum Allergy Rhinol 2014 0.75
121 The FACT score in predicting pneumococcal antibody levels in asthmatics. J Asthma 2014 0.75
122 Retraction: Blockade of allergic airway inflammation following systemic treatment with a B7-dendritic cell (PD-L2) cross-linking human antibody. J Immunol 2010 0.75